期刊文献+

含甲氨喋呤的磷酸钙骨水泥药物释放体系的制备及体外药物释放 被引量:4

Development of a Novel Drug Dilivery System Based on Calcium Phosphate Cement with Methotrexate and Its Drug Release Test in vitro
下载PDF
导出
摘要 目的观察含甲氨喋呤(MTX)的磷酸钙骨水泥(CPC)的药物释放体系在体外模拟体液中的药物释放情况。方法将MTX与CPC分别以0.1%、0.2%、0.5%质量分数混合,固化后放于37℃恒温模拟体液中,分别于2、5、10、16h、1、2、3、5、8、10、15、20、25、30、35、40、45d用高效液相色谱法测定模拟体液中MTX的浓度,绘制药物释放-时间曲线,分析药物释放规律。结果MTX-CPC复合物在模拟体液中的MTX释放缓慢而稳定,释放前期有明显的缓冲释放效应,符合Higuchi模型的药物释放规律。MTX释放浓度及速度与MTX在骨水泥中的包埋量有关,与骨水泥的厚度及形状无关。MTX的释放周期不受所含MTX量的影响。结论以CPC为载体,将MTX以适当浓度包埋,可制成稳定的药物释放体系。 Objective To develop a novel drug dilivery system based on calcium phosphate cement (CPC) with methotrexate (MTX) as a model drug and to study its drug release in vitro. Methods Three MTX mass fractions (0. 1% , 0. 2% , and 0. 5% ) were tested after solidification, and the compound of CPC- MTX were put into the simulated body fluid at 37℃. The concentration of MTX was tested by high-performance liquid chromatography at day 2, 5, 10, 16 hours, 1, 2, 3, 5, 8, 10, 15, 20, 25, 30, 35, 40, and 45 days. The drug dilivery curves were drawn and drug dilivery rules were analyzed. Results MTX was released slowly and stably from the compound of CPC-MTX. Remarked prophase of drug release was noted, which conformed with the Higuchi equation. The drug release rate and concentration was related with the concentrafion of MTX in compound but not with the thickness and shape of CPC. The releasing time was not affected by the concentration of MTX. Conclusion A stable drug dilivery system can be developed by loading proper concentration of MTX into CPC.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2007年第6期765-768,共4页 Acta Academiae Medicinae Sinicae
基金 山东省科技厅基金~~
关键词 磷酸钙骨水泥 甲氨喋呤 药物释放 骨修复 calcium phosphate cement methotrexate drug dilivery bone repair
  • 相关文献

参考文献12

二级参考文献44

  • 1杨志平,李建民.髂骨供区痛25例报告[J].中华骨科杂志,1993,13(6):464-465. 被引量:6
  • 2樊东辉,戴红莲,刘雁,魏荣梅.药物载体研究的现状和发展前景[J].武汉工业大学学报,1995,17(4):109-111. 被引量:6
  • 3许树柴,陈文治.硫酸妥布霉素骨外科临床应用观察[J].中国抗生素杂志,1996,21(5):398-399. 被引量:3
  • 4赵香兰 王建华 等.血清MTX7-OA-MTX的HPLC测定法及其与微生物法在大剂量MTX疗法监测应用中的比较[J].药物分析杂志,1988,8(5):278-278.
  • 5[1]Driessens FCM,BoltongMG,BemudzeO,etal.Formulation andsettingtimesofsomecalciumorthophosphatecements:Ap ilotstudy.JMaterSci:MaterinMed,1993; 4:503.
  • 6[2]DriessensFCM,BoltongMG,BemudzeO,etal.Effectivefor-m ulationsfortheprepartionofcalciumphosphatebonecements.J MaterSci:MaterinMed,1994; 5:164.
  • 7[3]Chow LC.Development of self-estting calcium phosphate cements.J Ceram Soci Jap,1991; 99 (10):954.
  • 8[4]Constantz BR,Ison IC,Fulmer MT et al.Skeletal repair by in situ formation of the mineral phase of bone.Science,1995; 267(5205):1796.
  • 9[5]Costantino PD,Friedman CD,Chow LC et al.Hydroxyapatite cement.1.Basic chemistry and histologic properties.Arch Otolaryngol Head Neck Surg,1991; 117 (4):379.
  • 10[6]Constantino PD,Friendman CD,Chow LC etal.Experimental Hydroxyapatite cement.cranioplasty.Plast Reconstr Surg,1992; 90 (2):174.

共引文献55

同被引文献72

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部